Back to top

Craig-Hallum Keeps Their Buy Rating on MaxCyte (MXCT)

In a report released yesterday, Matt Hewitt from Craig-Hallum maintained a Buy rating on MaxCyte. The company’s shares closed yesterday at $1.19. H...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

MaxCyte, Inc. (MXCT)